Predict your next investment

HEALTHCARE | Biotechnology
suvica.com

See what CB Insights has to offer

Stage

Grant | Alive

Total Raised

$1.5M

Last Raised

$1.5M | 6 yrs ago

About SuviCA

SuviCa is focused on the discovery and development of small molecules for the treatment of cancer. Currently, SuviCa has two small molecule protein synthesis inhibitors in pre-clinical development. SVC112 – With a patent filed for Composition of Matter protection, SVC112 has shown pre-clinical efficacy as monotherapy and in combination with standard therapies such as radiation and newly approved targeted agents. SVC112 is in pre-clinical development for a variety of cancer indications, including head & neck cancer, melanoma, colorectal cancer, and non-small cell lung cancer. SVC201 – Originally identified using SuviScreen, SVC201 shows potent anti-tumor activity against a panel of human colorectal cancer cell lines. Similar to SVC112, SVC201 inhibits protein synthesis; however, its mechanism of action is distinct from that of SVC112. SVC201 is currently in lead optimization.

SuviCA Headquarter Location

PO Box 3131

Boulder, Colorado, 80307,

United States

303-921-6680

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing SuviCA

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SuviCA is included in 4 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

C

Cancer Therapeutics

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

3,589 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

SuviCA Patents

SuviCA has filed 2 patents.

The 3 most popular patent topics include:

  • Cancer treatments
  • Experimental cancer drugs
  • Gene expression
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/10/2016

4/16/2019

Experimental cancer drugs, Oncology, Protein biosynthesis, Cancer treatments, Gene expression

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

8/10/2016

00/00/0000

Grant Date

4/16/2019

00/00/0000

Title

Subscribe to see more

Related Topics

Experimental cancer drugs, Oncology, Protein biosynthesis, Cancer treatments, Gene expression

Subscribe to see more

Status

Grant

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.